HPOX nanoparticles delivered intranasally significantly reduced
pulmonary inflammation and suppressed the iNOS expression. Given their excellent antioxidant and
anti-inflammatory activities, we anticipate that HPOX nanoparticles are highly potent for the treatment
of oxidative damage-related diseases, such as asthma